These may form a detrimental intergenerational cycle via the maternal metabolic disturbanceplacental functionfetal growth pathway (68, 120122)
Maggiano, A
Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S, Tsioufis KP, van Dis I, van Gelder IC, Wanner C, Williams B, ESC National Cardiac Societies, ESC Scientific Document Group
This market has grown explosively, projected to expand from 4.1 billion dollars to 13 billion by 2035
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
Regular use helps maintain steady antioxidant support